IVF Versus Surgery for Endometriosis Related Infertility
SVIDOE
IVF Versus Surgery for the Treatment of Infertility Associated to Ovarian and Deep Peritoneal Endometriosis
1 other identifier
interventional
206
1 country
3
Brief Summary
The management of endometriosis-related infertility remains controversial. In particular, there is an equipoise for infertile women with endometriotic lesions detected at ultrasound. These women can be managed with either surgery or in vitro fertilization (IVF). The two approaches radically differ and they have never been compared with a randomized trial. As a consequence, affected women currently receive contrasting information and the mode of treatment substantially differ among centres, reflecting the local expertise of physicians rather than clinical needs. The present study aims at clarify whether IVF could be superior to surgery in infertile women with endometriotic lesions detected at ultrasound. This topic will be addressed comparing the two approaches in terms of effectiveness and cost-effectiveness. In addition, the study will disentangling whether the endometriosis-related systemic inflammatory mechanisms may have an impact on the quality of folliculogenesis and on IVF outcomes. This specific objective will be pursued through the characterization and analysis of circulating extracellular vesicles (EV)-immunologic, proteomic and miRNA signatures and measurement of steroid hormones in follicular fluid.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2021
Longer than P75 for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 2, 2021
CompletedFirst Posted
Study publicly available on registry
February 8, 2021
CompletedStudy Start
First participant enrolled
March 16, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedFebruary 7, 2025
February 1, 2025
4.5 years
February 2, 2021
February 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Live birth rate from pregnancies started within 12 months since randomization
to assess whether IVF is more effective than surgery in obtaining a live birth and, if so, what is the magnitude of this benefit
up to 12 months since randomization
Secondary Outcomes (2)
Cost-effectiveness evaluation of the two different approaches in the treatment of endometriosis
12 months
Detachment of inflammatory mediators that might interfere with IVF through analysis of extracellular vescicles (EV).
3 months
Study Arms (2)
Surgery
ACTIVE COMPARATORPatients undergoing surgery for endometriosis, after surgery, will receive indications for seeking for a natural pregnancy up to 12 months from the time of randomization
In Vitro Fertilization
ACTIVE COMPARATORPatients included in the IVF arm will undergo three complete cycles of IVF (i.e. three oocytes retrievals regardless of the number of embryo transfers)
Interventions
Eligibility Criteria
You may qualify if:
- Age \< 40 years
- Pregnancy seeking for more than 12 months
- Regular menstrual cycle, i.e. mean cycle interval between 21 and 35 days
- Ultrasonographic diagnosis of ovarian endometriomas or deep peritoneal endometriosis.
- Normal seminal analysis based on WHO criteria
- Absence of ureteral stenosis or intestinal subocclusive symptoms
You may not qualify if:
- Previous surgery for endometriosis
- Previous IVF cycles
- Contraindication to pregnancy
- Hydrosalpinx
- Endometriomas with a mean diameter \> 4 cm
- Submucosal fibroids or large intramural or subserosal fibroids (≥ 5 cm).
- Doubtful sonographic findings that do not allow to reliably rule out malignancy.
- Obstacles to regular sexual intercourses (sexual disturbances or logistic problems)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicolead
- IRCCS San Raffaelecollaborator
- ASST Fatebenefratelli Saccocollaborator
- Ministero della Salute, Italycollaborator
Study Sites (3)
ASST-FBF-Sacco, Presidio Ospedaliero Macedonio Melloni
Milan, MI, 20100, Italy
IRCCS San Raffaele
Milan, MI, 20100, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Milan, MI, 20122, Italy
Related Publications (1)
Ottolina J, Vignali M, Papaleo E, Vigano P, Somigliana E, Ferrari S, Liprandi V, Belloni G, Reschini M, Candiani M, Vercellini P, Benaglia L. Surgery versus IVF for the treatment of infertility associated to ovarian and deep endometriosis (SVIDOE: Surgery Versus IVF for Deep and Ovarian Endometriosis). Clinical protocol for a multicenter randomized controlled trial. PLoS One. 2022 Aug 3;17(8):e0271173. doi: 10.1371/journal.pone.0271173. eCollection 2022.
PMID: 35921357DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laura Benaglia, MD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 2, 2021
First Posted
February 8, 2021
Study Start
March 16, 2021
Primary Completion
September 30, 2025
Study Completion
December 31, 2025
Last Updated
February 7, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share